Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Israel’s Parliament Hosts IASLC CEO Dr. Fred R. Hirsch
lungcanc
NCCN Guidelines Updated for 2018: Keeping Pace with Data
lungcanc
Fabrice Barlesi, MD
lungcanc
Frances Shepherd, MD
lungcanc
Pasi A. Janne, MD, PhD
lungcanc
Primo N. Lara, Jr., MD
lungcanc
The Long Road Home
lungcanc
EGFR-Targeted Therapy: A New Beginning
lungcanc
Highlights of the 8th Edition of the TNM Staging System: Practicalities...
lungcanc
The Lung Master Protocol: Results and Updates
lungcanc
1
...
24
25
26
...
53
Page 25 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
